We work with pharmaceutical and
biotechnology companies from around the globe.
QuantBio is a bioinformatics consulting company
with a focus on scientific excellence. We act as scientists for clients,
investigating problems and helping to answer and generate hypotheses. QuantBio specializes
in analytics, and specifically drug development, both pre-clinical and clinical.
Sara Selitsky, PhD, is the founder and CEO of QuantBio. She
is an Assistant Professor at the University of North Carolina in the Cancer Center’s
Bioinformatics Core. Her research focuses on cancer genomics, immunology, and virology.
Sara has worked as a bioinformatics consultant for pharmaceutical and biotechnology companies since 2014,
specializing in data analytics for drug development.
QuantBio partners with other consultants with years of
post-graduate experience in genomics and bioinformatics.